Market Size of Saudi Arabia Self-Monitoring Blood Glucose Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 117 Million |
| Market Size (2029) | USD 162 Million |
| CAGR (2024 - 2029) | 6.42 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Saudi Arabia Self-Monitoring Blood Glucose Devices Market Analysis
The Saudi Arabia Self-Monitoring Blood Glucose Devices Market size is estimated at USD 117 million in 2024, and is expected to reach USD 162 million by 2029, growing at a CAGR of 6.42% during the forecast period (2024-2029).
Blood glucose monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood glucose monitoring values provide feedback and guidance on how to make health behavior changes when needed.
Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
Innovative technologies, such as digital health apps that display and summarize individual blood glucose measurements and additional relevant data such as insulin doses, meals, and physical activity, can further support self-management while decreasing disease burden and benefiting overall diabetes care. Integration of blood glucose monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes with the additional support needed to improve critical outcomes, thereby enhancing market prospects in the years to come.
The World Health Assembly Resolution 2022 recommended the integration of prevention and treatment of diabetes into primary health services, the development of pathways for a substantial increase in access to insulin, the promotion of convergence and harmonization of regulatory requirements for diabetes medicines and technologies, and improved diabetes monitoring and surveillance.
Furthermore, it involves the WHO advising the Member States to ensure the uninterrupted treatment of people living with diabetes in humanitarian emergencies. This important milestone provides a global mandate for diabetes efforts for the next decade. Such initiatives are expected to create awareness among the public regarding the monitoring and control of diabetes, thereby enhancing market prospects in the years to come.
